經營團隊
-
Antony Hsu
President
Antony Hsu
PresidentAntony Hsu is responsible for Caliway’s business development activities, including fundraising, commercialization and corporate development, and launch planning.
-
Vivian Ling
Chief Executive Officer/Chief R&D Officer
Vivian Ling
Chief Executive Officer/Chief R&D OfficerVivian Ling is responsible for Caliway’s Research & Development, including drug discovery research, non-clinical and clinical development, and regulatory affairs.
-
April Yuan
VP
April Yuan
VPApril Yuan is responsible for Caliway's corporate development affairs, including out-licensing negotiation, public relations, and medical affairs.
-
Ellen Chang
Finance & Accounting Director and Deputy Spokesperson
Ellen Chang
Finance & Accounting Director and Deputy SpokespersonFinance Director Ellen Chang has over 10 years of experience in capital market communications and fundraising in the biotech industry. She is responsible for financial affairs and investor relations.
Scientific Team
-
Industry-leading dermatologist with 40+ years of experience
-
Board-certified dermatologist / dermatologic surgeon for 30+ years
-
Dr. Chang is mainly responsible for the clinical application of new drugs.
-
Dr. Chang is the dean of Aphrodite Ritz clinic and served as a plastic surgeon at Chang Gung Memorial Hospital.
